← Back to Search

Imaging for Cardiovascular Disease

N/A
Recruiting
Led By Rukhsana Mirza, MD
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 hours
Awards & highlights
No Placebo-Only Group

Summary

This trial will test whether abnormalities in the retina's blood vessels, as seen on a special kind of OCT scan, are linked with the severity of cardiovascular disease as measured by ultrasound of the carotid arteries.

Who is the study for?
This trial is for adults aged 18-80 who are being checked for heart disease and can undergo a clinical eye exam. They must be able to consent, not have any known eye diseases except for needing glasses or contacts, and should be getting standard carotid artery scans.
What is being tested?
The study is testing if a special type of eye scan called SS-OCTA can show changes in the tiny blood vessels of the retina that match up with how severe someone's heart disease is, as seen on neck artery ultrasounds.
What are the potential side effects?
SS-OCTA is generally safe but may cause discomfort from bright lights or sitting still during the scan. There's also a small risk of temporary blurry vision after the test.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 hours for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Correlation with and prediction of the presence/degree of carotid occlusive disease as determined by carotid duplex ultrasonography

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: All ParticipantsExperimental Treatment1 Intervention
50 participants identified in the Northwestern Medicine Division of Vascular Surgery.

Find a Location

Who is running the clinical trial?

Northwestern UniversityLead Sponsor
1,652 Previous Clinical Trials
961,465 Total Patients Enrolled
Rukhsana Mirza, MDPrincipal InvestigatorNorthwestern University
~0 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top